Piperazine,1,4-bis(2-oxiranylmethyl)-

Modify Date: 2024-01-28 10:45:46

Piperazine,1,4-bis(2-oxiranylmethyl)- Structure
Piperazine,1,4-bis(2-oxiranylmethyl)- structure
 Common Name Piperazine,1,4-bis(2-oxiranylmethyl)-
CAS Number 2917-98-8 Molecular Weight 198.26200
Density 1.206g/cm3 Boiling Point 304.5ºC at 760 mmHg
Molecular Formula C10H18N2O2 Melting Point N/A
MSDS N/A Flash Point 93.5ºC

 Names

Name 1,4-bis(oxiran-2-ylmethyl)piperazine
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.206g/cm3
Boiling Point 304.5ºC at 760 mmHg
Molecular Formula C10H18N2O2
Molecular Weight 198.26200
Flash Point 93.5ºC
Exact Mass 198.13700
PSA 31.54000
Vapour Pressure 0.000873mmHg at 25°C
Index of Refraction 1.553

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TK9140000
CHEMICAL NAME :
Piperazine, 1,4-bis(2,3-epoxypropyl)-
CAS REGISTRY NUMBER :
2917-98-8
BEILSTEIN REFERENCE NO. :
0081824
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C10-H18-N2-O2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
91380 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
40770 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
199 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

 Safety Information

HS Code 2933599090

 Synthetic Route

Piperazine structure

Piperazine

CAS#:110-85-0
Epichlorohydrin structure

Epichlorohydrin

CAS#:106-89-8

~62%

Piperazine,1,4-bis(2-oxiranylmethyl)- Structure

Piperazine,1,4-...

CAS#:2917-98-8
Literature: Chezlov, I. G.; Zavlin, P. M.; Kuznetsov, L. L. Russian Journal of Applied Chemistry, 1998 , vol. 71, # 1 p. 155 - 161 Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1998 , vol. 71, # 1 p. 149 - 156

 Customs

HS Code 2933599090
Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

Diglycidyl piperazine
USAF EL-26
Diepoxy piperazine
Epoxypiperazine
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Piperazine,1,4-bis(2-oxiranylmethyl)- suppliers

Piperazine,1,4-bis(2-oxiranylmethyl)- price

Related Compounds: More...
Piperazine,1,4-bis(2-bromo-3-methyl-1-oxobutyl)- (9CI)
6632-82-2
Piperazine,1,4-bis(2-bromo-1-oxobutyl)- (9CI)
6303-01-1
Piperazine,1,4-bis(2-phenoxyethyl)-
2465-64-7
Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate
68189-43-5
Piperazine,1,4-bis[2-(2-pyridinyl)ethyl]-
14549-75-8
Piperazine, 1,4-bis(2-bromo-1-oxopentyl)- (9CI)
6302-67-6
Piperazine,1,4-bis(2-chloropropyl)-, hydrochloride (1:2)
49562-08-5
Piperazine, 1,4-bis[ (2, 3-dihydro-1,4-benzodioxin-2-yl)methyl]-
7762-32-5
Piperazine,1,4-bis(2-quinoxalinylcarbonyl)- (7CI,8CI)
6960-18-5
Chemsrc provides Piperazine,1,4-bis(2-oxiranylmethyl)-(CAS#:2917-98-8) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Piperazine,1,4-bis(2-oxiranylmethyl)- are included as well.>> amp version: Piperazine,1,4-bis(2-oxiranylmethyl)-

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved